Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of cyclin-dependent protein serine/threonine kinase activity

IPO5 IPO7 CCNB1 LATS1 LATS2 CCNB2 CDC25C

5.95e-07961057GO:0000079
GeneOntologyBiologicalProcessregulation of cyclin-dependent protein kinase activity

IPO5 IPO7 CCNB1 LATS1 LATS2 CCNB2 CDC25C

7.86e-071001057GO:1904029
GeneOntologyBiologicalProcessnegative regulation of cyclin-dependent protein serine/threonine kinase activity

IPO5 IPO7 LATS1 LATS2

1.37e-05291054GO:0045736
GeneOntologyBiologicalProcessregulation of transferase activity

IPO5 IPO7 ERN1 RGPD1 CBL RYK CCNB1 BMI1 RASGRP1 LATS1 LATS2 CCNB2 SETD7 PLEC CDC25C

1.48e-0581010515GO:0051338
GeneOntologyBiologicalProcessnegative regulation of cyclin-dependent protein kinase activity

IPO5 IPO7 LATS1 LATS2

1.57e-05301054GO:1904030
GeneOntologyBiologicalProcessregulation of kinase activity

IPO5 IPO7 ERN1 RGPD1 CBL RYK CCNB1 RASGRP1 LATS1 LATS2 CCNB2 PLEC CDC25C

4.56e-0568610513GO:0043549
GeneOntologyBiologicalProcessnegative regulation of protein modification process

ATG5 IPO5 IPO7 ENPP1 CBL CCNB1 LATS1 LATS2 PIAS3 PLEC HDAC2

6.03e-0551210511GO:0031400
GeneOntologyBiologicalProcessinner cell mass cell fate commitment

LATS1 LATS2

7.68e-0531052GO:0001827
GeneOntologyBiologicalProcessinner cell mass cellular morphogenesis

LATS1 LATS2

7.68e-0531052GO:0001828
GeneOntologyBiologicalProcessregulation of protein serine/threonine kinase activity

IPO5 IPO7 ERN1 CCNB1 RASGRP1 LATS1 LATS2 CCNB2 CDC25C

8.99e-053581059GO:0071900
GeneOntologyCellularComponentSWI/SNF superfamily-type complex

TRRAP BPTF SF3B1 CHD5 HDAC2

1.08e-04961025GO:0070603
GeneOntologyCellularComponentcatalytic step 2 spliceosome

ESS2 EFTUD2 SF3B1 SF3B6 MTREX

1.13e-04971025GO:0071013
GeneOntologyCellularComponentnuclear protein-containing complex

IPO5 ESS2 IPO7 RGPD1 MCM2 XPA RBM48 TRRAP EFTUD2 BMI1 BPTF SF3B1 CHD5 SF3B6 MTREX MGA HDAC2

3.45e-04137710217GO:0140513
GeneOntologyCellularComponentATPase complex

TRRAP BPTF SF3B1 CHD5 HDAC2

4.27e-041291025GO:1904949
GeneOntologyCellularComponentspliceosomal complex

ESS2 RBM48 EFTUD2 SF3B1 SF3B6 MTREX

6.54e-042151026GO:0005681
MousePhenoincreased central memory CD4-positive, alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

9.21e-0624794MP:0010841
MousePhenoabnormal central memory CD4-positive, alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

2.32e-0530794MP:0012771
MousePhenoabnormal central memory CD4-positive, alpha-beta T cell morphology

DOCK8 RASGRP1 DIAPH1 VAV1

2.32e-0530794MP:0010840
MousePhenoincreased central memory CD8 positive, alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

4.33e-0535794MP:0010847
MousePhenoincreased effector memory CD4-positive, alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

8.16e-0541794MP:0010844
MousePhenoabnormal central memory CD8-positive, alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

8.98e-0542794MP:0012772
MousePhenoabnormal central memory CD8 positive, alpha-beta T cell morphology

DOCK8 RASGRP1 DIAPH1 VAV1

8.98e-0542794MP:0010846
MousePhenoabnormal effector memory CD4-positive, alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

1.52e-0448794MP:0012770
MousePhenoabnormal effector memory CD4-positive, alpha-beta T cell morphology

DOCK8 RASGRP1 DIAPH1 VAV1

1.52e-0448794MP:0010843
MousePhenodecreased CD8-positive, naive alpha-beta T cell number

DOCK8 RASGRP1 DIAPH1 VAV1

2.08e-0452794MP:0013435
MousePhenoabnormal CD4-positive, alpha-beta memory T cell morphology

DOCK8 RASGRP1 DIAPH1 VAV1

2.59e-0455794MP:0010834
DomainARM-type_fold

IPO5 IPO8 IPO7 DOCK8 RANBP6 NBEA TRRAP RYR3 SF3B1 DIAPH1

1.96e-0533910410IPR016024
DomainNYAP1/NYAP2

NYAP2 NYAP1

3.07e-0521042IPR026722
DomainNYAP_C

NYAP2 NYAP1

3.07e-0521042IPR029353
DomainNYAP_C

NYAP2 NYAP1

3.07e-0521042PF15452
DomainZnf_RING/FYVE/PHD

UBE4B PCLO ASH1L RNF213 CBL UBR7 BMI1 BPTF PIAS3 CHD5 IRF2BPL

5.01e-0545910411IPR013083
DomainIMPORTIN_B_NT

IPO5 IPO8 IPO7

5.84e-05141043PS50166
DomainCse1

IPO8 IPO7

9.18e-0531042PF08506
DomainCse1

IPO8 IPO7

9.18e-0531042IPR013713
DomainImportin-beta_N

IPO5 IPO8 IPO7

1.08e-04171043IPR001494
DomainARM-like

IPO5 IPO8 IPO7 DOCK8 RANBP6 NBEA TRRAP SF3B1

1.34e-042701048IPR011989
PathwayKEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M

CCNB1 CCNB2 CDC25C

2.21e-0510823M47572
PathwayKEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M

CCNB1 CCNB2 CDC25C

3.03e-0511823M47573
PathwayREACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS

CCNB1 CCNB2 CDC25C

1.01e-0416823M26971
PathwayKEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M

CCNB1 CCNB2

3.30e-045822M49022
PathwayREACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7

CCNB1 CCNB2

3.30e-045822MM14918
PathwayREACTOME_G2_M_DNA_REPLICATION_CHECKPOINT

CCNB1 CCNB2

3.30e-045822M27669
PathwayREACTOME_G2_M_DNA_REPLICATION_CHECKPOINT

CCNB1 CCNB2

3.30e-045822MM15382
PathwayREACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION

CCNB1 CCNB2 CDC25C

3.98e-0425823M808
PathwayREACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION

CCNB1 CCNB2 CDC25C

3.98e-0425823MM15379
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

IPO5 TPT1 ZC3H14 SET IPO7 THUMPD1 RNF213 MCM2 CHD9 XPA PHAX TRRAP BPTF UBA1 SF3B1 DIAPH1 IRF2BPL PLEC MTREX IMMT HDAC2

3.57e-1210141062132416067
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

ATG5 IPO5 SET IPO7 MYO1E UBE4B THUMPD1 RANBP6 IREB2 MCM2 PHAX UBR7 EFTUD2 UBA1 SETSIP DIAPH1 IRF2BPL PLEC DYNC1LI2

8.01e-0814551061922863883
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

IPO5 ZC3H14 IPO7 MCM2 TRRAP F5 EFTUD2 BPTF UBA1 SF3B1 SF3B6 PLEC MTREX MGA IMMT HDAC2

8.77e-0810241061624711643
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ESS2 IPO7 BMI1 LATS1 PIAS3 CHD5 IRF2BPL PLEC NYAP1 MGA IQCE

8.82e-084301061135044719
Pubmed

LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.

IPO5 SET IPO7 MCM2 CBL TRRAP UBA1 SF3B1 DIAPH1 PLEC

1.08e-073441061030333137
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

IPO5 SET IPO8 IPO7 RANBP6 MCM2 MRPL45 PHAX TRRAP CCNB1 EFTUD2 UBA1 SF3B1 SETSIP MTREX IMMT MRPL1 HDAC2

1.15e-0713351061829229926
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

IPO5 IPO7 DOCK8 CCNB1 EFTUD2 SF3B1 VPS33B SF3B6 DIAPH1 PLEC MTREX DYNC1LI2

2.27e-075821061220467437
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

TPT1 ZC3H14 SET ESS2 IPO8 IPO7 DOCK8 CHD9 TRRAP CCNB1 BPTF UBA1 SF3B6 C1orf52 MTREX HDAC2

2.39e-0711031061634189442
Pubmed

TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities.

SET CCNB1 CCNB2

2.74e-075106318591933
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

IPO5 ESS2 IPO7 CHD9 PHAX TRRAP UBR7 BMI1 BPTF CHD5 MGA HDAC2

3.62e-076081061236089195
Pubmed

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.

CCNB1 CCNB2 CDC25C

5.47e-07610637474100
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

IPO5 IPO8 IPO7 MCM2 EFTUD2 UBA1 SF3B1 DIAPH1 PLEC MTREX IMMT HDAC2

6.01e-076381061233239621
Pubmed

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

IPO7 CBL UBA1 SF3B6 C1orf52 PLEC SKA3 ACAP2 VAV1

7.59e-07327106915592455
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

IPO5 ZC3H14 ESS2 IPO8 DOCK8 MCM2 NBEA UBA1 SF3B6 PLEC PPIP5K2 MGA VAV1 HDAC2

7.85e-079161061432203420
Pubmed

SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.

IPO5 IPO8 IPO7 RANBP6 TBC1D9 EFTUD2 SF3B1 SF3B6 SEC63 MGA ACAP2 IMMT

8.17e-076571061236180527
Pubmed

Signal recognition particle protein 19 is imported into the nucleus by importin 8 (RanBP8) and transportin.

IPO5 IPO8 IPO7

9.55e-077106311682607
Pubmed

HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle.

CCNB1 CCNB2 CDC25C

9.55e-07710639520381
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

IPO5 IPO7 CCNB1 EFTUD2 VPS33B DIAPH1 SETD7 MTREX IMMT DYNC1LI2 HDAC2

1.20e-065601061135241646
Pubmed

TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.

IPO5 IPO7 MCM2 BPTF SF3B1 MTREX IMMT

1.35e-06179106736261009
Pubmed

NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.

TRRAP BPTF MTREX HDAC2

1.36e-0627106423395962
Pubmed

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.

IPO5 SET MCM2 SF3B1 SETSIP SF3B6 HDAC2

1.40e-06180106730110629
Pubmed

Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E.

IPO5 IPO8 IPO7

1.52e-068106327114554
Pubmed

14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 Vpr.

IPO5 CCNB1 CDC25C

1.52e-068106318445273
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

TPT1 SET PCDHGA1 PCLO ASH1L RGPD1 PTPN21 BPTF LATS1 SF3B1 LATS2 SETSIP CHD5 PLEC PPIP5K2 IMMT HDAC2

1.71e-0614421061735575683
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ATG5 IPO5 MYO1E UBE4B ASH1L APBA1 CHD9 NBEA REV3L RYR3 NAA25 SF3B1 PIAS3 PLEC IMMT ECE2

1.78e-0612851061635914814
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

SET THUMPD1 MCM2 CHD9 MRPL45 PHAX DNAH7 EFTUD2 UBA1 SF3B1 CHD5 SF3B6 MTREX IMMT HDAC2

2.27e-0611531061529845934
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

IPO5 IPO7 MCM2 CHD9 EFTUD2 BPTF UBA1 SF3B1 DIAPH1 PLEC

2.88e-064941061026831064
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

ATG5 IPO7 UBE4B TUT7 MCM2 TRRAP EFTUD2 UBA1 SF3B1 VPS33B SF3B6 DIAPH1 PLEC MTREX MGA IMMT

3.44e-0613531061629467282
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

UBE4B MCM2 TRRAP TBC1D9 EFTUD2 BPTF UBA1 LATS1 SF3B1 IRF2BPL PLEC DYNC1LI2

4.42e-067741061215302935
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

IPO5 ZC3H14 IPO7 TUT7 TRRAP BPTF SF3B1 PLEC MTREX IMMT HDAC2

5.21e-066531061122586326
Pubmed

GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.

IPO7 UBA1 SF3B1 ALDH1L2 MTREX MGA IMMT

5.44e-06221106729991511
Pubmed

Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

CCNB1 CCNB2 CDC25C

5.93e-061210637494303
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

IPO5 SET IPO8 IPO7 DNAH10 PCLO MCM2 PLA2G15 EFTUD2 UBA1 SF3B1 VPS33B DIAPH1 MTREX SEC63 IMMT

6.61e-0614251061630948266
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

ZC3H14 PHAX CBL TRRAP BPTF UBA1 LATS1 SKA3 MGA HDAC2

7.27e-065491061038280479
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

IPO5 SET IPO8 IPO7 MYO1E RANBP6 RNF213 MCM2 MRPL45 CCNB1 EFTUD2 SF3B1 IRF2BPL MTREX SEC63 MRPL1

7.53e-0614401061630833792
Pubmed

PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.

PCLO BMI1 MGA HDAC2

7.57e-0641106422325352
Pubmed

Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.

LATS1 LATS2

9.20e-062106225482410
Pubmed

Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells.

LATS1 LATS2

9.20e-062106230671453
Pubmed

Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.

CBL VAV1

9.20e-062106220189481
Pubmed

Crystal structure of a core spliceosomal protein interface.

SF3B1 SF3B6

9.20e-062106216432215
Pubmed

A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.

LATS1 LATS2

9.20e-062106232826458
Pubmed

5'-UTR and ORF elements, as well as the 3'-UTR regulate the translation of Cyclin.

CCNB1 CCNB2

9.20e-062106232439164
Pubmed

AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.

LATS1 LATS2

9.20e-062106229730476
Pubmed

N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.

LATS1 LATS2

9.20e-062106223230145
Pubmed

Assignment of two human cell cycle genes, CDC25C and CCNB1, to 5q31 and 5q12, respectively.

CCNB1 CDC25C

9.20e-06210621386342
Pubmed

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.

LATS1 LATS2

9.20e-062106231848340
Pubmed

Functional analysis of the P box, a domain in cyclin B required for the activation of Cdc25.

CCNB1 CDC25C

9.20e-06210628402895
Pubmed

Expression of LATS family proteins in ovarian tumors and its significance.

LATS1 LATS2

9.20e-062106225841306
Pubmed

Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells.

CBL VAV1

9.20e-06210629200440
Pubmed

Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway.

CBL EPHB1

9.20e-062106218034775
Pubmed

Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.

LATS1 LATS2

9.20e-062106224026096
Pubmed

Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.

CCNB1 CCNB2

9.20e-062106238241547
Pubmed

Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.

LATS1 LATS2

9.20e-062106232423384
Pubmed

Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.

LATS1 LATS2

9.20e-062106234060480
Pubmed

Isolation of the murine cyclin B2 cDNA and characterization of the lineage and temporal specificity of expression of the B1 and B2 cyclins during oogenesis, spermatogenesis and early embryogenesis.

CCNB1 CCNB2

9.20e-06210628375336
Pubmed

Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.

LATS1 LATS2

9.20e-062106217049657
Pubmed

The kinetics of G2 and M transitions regulated by B cyclins.

CCNB1 CCNB2

9.20e-062106224324638
Pubmed

Structural model of the p14/SF3b155 · branch duplex complex.

SF3B1 SF3B6

9.20e-062106221062891
Pubmed

Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.

LATS1 LATS2

9.20e-062106231268774
Pubmed

The Translation of Cyclin B1 and B2 is Differentially Regulated during Mouse Oocyte Reentry into the Meiotic Cell Cycle.

CCNB1 CCNB2

9.20e-062106229074977
Pubmed

The Hippo pathway regulates human megakaryocytic differentiation.

LATS1 LATS2

9.20e-062106227786336
Pubmed

Cyclin B1 is essential for mitosis in mouse embryos, and its nuclear export sets the time for mitosis.

CCNB1 CCNB2

9.20e-062106229074707
Pubmed

Cell type-dependent function of LATS1/2 in cancer cell growth.

LATS1 LATS2

9.20e-062106230531839
Pubmed

Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.

LATS1 LATS2

9.20e-062106215746036
Pubmed

Cbl enforces Vav1 dependence and a restricted pathway of T cell development.

CBL VAV1

9.20e-062106221490975
Pubmed

Cyclin B2 can compensate for Cyclin B1 in oocyte meiosis I.

CCNB1 CCNB2

9.20e-062106230097513
Pubmed

Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.

LATS1 LATS2

9.20e-062106219799973
Pubmed

LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control.

LATS1 LATS2

9.20e-062106232015438
Pubmed

Cbl-mediated ubiquitinylation and negative regulation of Vav.

CBL VAV1

9.20e-062106212881521
Pubmed

A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.

LATS1 LATS2

9.20e-062106225044019
Pubmed

Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2.

CCNB1 CCNB2

9.20e-062106217533373
Pubmed

Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero.

CCNB1 CCNB2

9.20e-06210629539739
Pubmed

Overexpression of B-type cyclins alters chromosomal segregation.

CCNB1 CCNB2

9.20e-062106211960377
Pubmed

Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer.

UBE4B CBL UBA1

9.77e-0614106329326975
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

ATG5 ZC3H14 TUT7 RGPD1 UBA1 SF3B6 PLEC MTREX IMMT VAV1 HDAC2

1.01e-057011061130196744
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

ZC3H14 ESS2 MCM2 RYK EFTUD2 BPTF UBA1 SF3B1 SF3B6 PLEC MTREX SEC63 HDAC2

1.02e-059891061336424410
Pubmed

ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.

IPO5 IPO7 MCM2 EFTUD2 UBA1 MTREX SEC63 IMMT KLB

1.04e-05451106936168627
Pubmed

Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.

IPO8 IPO7 POMGNT1 EFTUD2 UBA1 SF3B1 SF3B6 SKA3 MTREX CDC25C

1.05e-055731061028330616
Pubmed

Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.

ATG5 IPO5 ESS2 THUMPD1 PHAX UBR7 CCNB1 UBA1 SETD7 DYNC1LI2 TBCEL

1.05e-057041061132994395
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

IPO5 SET IPO8 RGPD1 CCNB1 EFTUD2 UBA1 SF3B1 CCNB2 SF3B6 C1orf52 CDC25C DYNC1LI2 HDAC2

1.13e-0511551061420360068
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

ZC3H14 IPO8 MCM2 PHAX EFTUD2 UBA1 SF3B1 SETSIP SF3B6 MTREX ACAP2

1.20e-057141061128302793
Pubmed

Centrosome-related genes, genetic variation, and risk of breast cancer.

MCM2 CCNB1 LATS1 LATS2 CDC25C

1.57e-05102106520508983
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

UBE4B RNF213 TRRAP SF3B6 DIAPH1

1.73e-05104106531240132
Pubmed

Transcription factor Foxp3 and its protein partners form a complex regulatory network.

RGPD1 CCNB1 BPTF IRF2BPL PLEC SKA3 VAV1 HDAC2

1.85e-05370106822922362
Pubmed

Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

RGPD1 EFTUD2 BPTF SF3B1 CHD5 PLEC HDAC2

2.04e-05271106732433965
Pubmed

Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.

IPO5 SET RNF213 MCM2 EFTUD2 UBA1 DIAPH1 ACAP2 HDAC2

2.16e-05495106928581483
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

SET CHD9 MRPL45 TRRAP EFTUD2 BPTF SF3B1 SF3B6 PLEC PPIP5K2 SEC63 DYNC1LI2 HDAC2

2.61e-0510821061338697112
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

IPO5 SET IPO7 CHD9 BMI1 MTREX MRPL1

2.63e-05282106723667531
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

IPO5 ZC3H14 SET IPO7 CHD9 EFTUD2 LATS1 SF3B1 DIAPH1 MTREX MGA IMMT DYNC1LI2 HDAC2

2.64e-0512471061427684187
Pubmed

Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.

CCNB1 CCNB2

2.76e-05310621717476
Pubmed

Cbl-b regulates the CD28 dependence of T-cell activation.

CBL VAV1

2.76e-053106210646609
Pubmed

A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.

LATS1 LATS2

2.76e-053106230308519
Pubmed

PP2A inhibitor SET promotes mTORC1 and Bmi1 signaling through Akt activation and maintains the colony-formation ability of cancer cells.

SET BMI1

2.76e-053106238141761
Pubmed

Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients.

F5 FGG

2.76e-053106227999448
Pubmed

Fortilin binds IRE1α and prevents ER stress from signaling apoptotic cell death.

TPT1 ERN1

2.76e-053106228550308
Pubmed

Molecular architecture of the multiprotein splicing factor SF3b.

SF3B1 SF3B6

2.76e-053106212738865
Pubmed

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.

CCNB1 CCNB2

2.76e-053106232863381
Pubmed

The carboxy-terminal region of CD5 is required for c-CBL mediated TCR signaling downmodulation in thymocytes.

CBL VAV1

2.76e-053106223376399
Pubmed

Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.

LATS1 LATS2

2.76e-053106224012335
Pubmed

Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus.

CCNB1 CCNB2

2.76e-05310627737117
InteractionITGB3 interactions

IPO5 IPO7 MCM2 CBL TRRAP UBA1 SF3B1 DIAPH1 FGG PLEC

2.22e-0817010610int:ITGB3
InteractionSUZ12 interactions

ZC3H14 SET MYO1E MCM2 TRRAP EFTUD2 BPTF NAA25 SF3B1 LATS2 SF3B6 PLEC IMMT VAV1 HDAC2

1.38e-0664410615int:SUZ12
InteractionMDM2 interactions

TPT1 SET IPO7 UBE4B IREB2 CBL EFTUD2 LATS1 SF3B1 LATS2 SETD7 MTREX CDC25C UBE2Z HDAC2

1.80e-0665810615int:MDM2
InteractionEED interactions

IPO5 TPT1 IPO7 MYO1E UBE4B MCM2 CBL TRRAP EFTUD2 BMI1 BPTF NAA25 UBA1 SF3B1 SF3B6 PLEC MTREX MGA IMMT UBE2Z VAV1 HDAC2

5.05e-06144510622int:EED
InteractionCSNK2A2 interactions

IPO5 SET ESS2 ASH1L PTPN21 TRRAP TTLL7 EFTUD2 BMI1 LATS1 CCNB2 CDC25C MGA DYNC1LI2 HDAC2

5.22e-0671810615int:CSNK2A2
InteractionKPNB1 interactions

IPO5 ZC3H14 IPO8 IPO7 RGPD1 RANBP6 MCM2 PHAX CCNB1 EFTUD2 BMI1 CDC25C HDAC2

5.63e-0654410613int:KPNB1
InteractionUBE2D2 interactions

TPT1 UBE4B RNF213 MCM2 CBL CCNB1 BMI1 UBA1 PLEC PPIP5K2

6.94e-0631810610int:UBE2D2
InteractionSPICE1 interactions

IPO5 IPO8 IPO7 CCNB1 LATS1 LATS2 VPS33B SKA3

7.67e-061911068int:SPICE1
InteractionH3-3A interactions

IPO5 SET ESS2 ASH1L MCM2 CHD9 PHAX TRRAP UBR7 BPTF SF3B1 CHD5 SETD7 MGA HDAC2

8.67e-0674910615int:H3-3A
InteractionKPNA1 interactions

ATG5 IPO5 MCM2 PHAX TRRAP EFTUD2 BPTF SF3B1 SKA3 HDAC2

1.64e-0535110610int:KPNA1
InteractionH3-4 interactions

SET DNAH10 MCM2 TRRAP BMI1 BPTF CHD5 SETD7 PLEC MGA HDAC2

2.42e-0544810611int:H3-4
InteractionSNW1 interactions

ATG5 ESS2 CCNB1 EFTUD2 BMI1 UBA1 SF3B1 VPS33B SF3B6 DIAPH1 PLEC MTREX DYNC1LI2 HDAC2

3.68e-0574710614int:SNW1
InteractionRAN interactions

IPO5 IPO8 IPO7 ASH1L RGPD1 RANBP6 PHAX EFTUD2 SF3B6 IQCE HDAC2

4.12e-0547510611int:RAN
InteractionRECQL4 interactions

IPO5 SET IPO8 IPO7 APBA1 RANBP6 MCM2 MRPL45 PHAX TRRAP CCNB1 EFTUD2 UBA1 SF3B1 SETSIP PLEC MTREX IMMT MRPL1 HDAC2

4.13e-05141210620int:RECQL4
InteractionCYLD interactions

ATG5 IPO5 IPO8 RNF213 EFTUD2 SF3B1 LATS2 VPS33B SF3B6 PLEC SKA3 MTREX MGA ACAP2 MRPL1

4.82e-0586810615int:CYLD
InteractionYAP1 interactions

IPO5 ZC3H14 ESS2 IPO7 THUMPD1 PTPN21 PHAX TRRAP BPTF UBA1 LATS1 LATS2 PLEC SKA3 MGA IMMT HDAC2

5.54e-05109510617int:YAP1
InteractionMAD2L1 interactions

ESS2 IPO7 CHD9 REV3L BPTF C1orf52 PPIP5K2 MGA

5.61e-052521068int:MAD2L1
InteractionH3C3 interactions

IPO5 ESS2 IPO7 MCM2 TRRAP UBR7 BMI1 BPTF CHD5 MGA HDAC2

5.97e-0549510611int:H3C3
InteractionCDK2 interactions

TPT1 SET IPO7 MCM2 CCNB1 EFTUD2 BMI1 NAA25 UBA1 LATS1 LATS2 CCNB2 PLEC CDC25C

6.12e-0578310614int:CDK2
InteractionIRF1 interactions

SET CBL PIAS3 SEC63 MGA

7.67e-05831065int:IRF1
InteractionPLK1 interactions

TPT1 TUT7 MCM2 CBL TRRAP TBC1D9 CCNB1 LATS1 SKA3 CDC25C HDAC2

7.80e-0551010611int:PLK1
InteractionHSF1 interactions

IPO5 TPT1 ZC3H14 IPO8 IPO7 MCM2 TRRAP EFTUD2 SF3B1 MGA IMMT HDAC2

8.61e-0560910612int:HSF1
InteractionKPNA2 interactions

IPO7 MCM2 RBM48 PHAX TRRAP EFTUD2 BMI1 UBA1 SF3B1 IMMT HDAC2

9.11e-0551910611int:KPNA2
InteractionC9orf78 interactions

IPO5 IPO7 UBR7 CCNB1 EFTUD2 VPS33B DIAPH1 SETD7 MTREX IMMT DYNC1LI2 HDAC2

1.02e-0462010612int:C9orf78
InteractionXRCC6 interactions

TPT1 SET MCM2 PHAX CBL TRRAP RYK CCNB1 EFTUD2 BPTF UBA1 SF3B1 DIAPH1 MGA VAV1

1.02e-0492810615int:XRCC6
InteractionNCBP1 interactions

IPO5 PHAX TRRAP CCNB1 EFTUD2 BMI1 SF3B1 MTREX DYNC1LI2

1.03e-043531069int:NCBP1
InteractionBAG2 interactions

ESS2 MCM2 CBL EFTUD2 BMI1 BPTF LATS2 CHD5 C1orf52 IRF2BPL SKA3 PPIP5K2

1.05e-0462210612int:BAG2
InteractionSF3B5 interactions

TRRAP EFTUD2 LATS1 SF3B1 SF3B6 VAV1

1.09e-041431066int:SF3B5
InteractionH2AC14 interactions

MYO1E MCM2 PHAX CBL EFTUD2 LATS1

1.14e-041441066int:H2AC14
InteractionOTUB1 interactions

IPO5 TPT1 ERN1 UBE4B IREB2 CCNB1 SETD7 IMMT UBE2Z

1.15e-043581069int:OTUB1
InteractionTHRAP3 interactions

ZC3H14 MYO1E PCLO PHAX EFTUD2 BMI1 SF3B1 SF3B6 PLEC SKA3

1.16e-0444310610int:THRAP3
InteractionUBE2L3 interactions

TPT1 UBE4B RNF213 MCM2 CBL EFTUD2 UBA1

1.27e-042111067int:UBE2L3
InteractionOGT interactions

ATG5 IPO5 ESS2 THUMPD1 PHAX UBR7 CCNB1 EFTUD2 BMI1 UBA1 LATS1 SETD7 DYNC1LI2 TBCEL HDAC2

1.32e-0495010615int:OGT
InteractionFBL interactions

IPO5 SET IPO8 IPO7 TUT7 RANBP6 MCM2 PHAX TRRAP EFTUD2 BMI1 LATS1

1.35e-0463910612int:FBL
InteractionMRPL35 interactions

IPO5 IPO7 RANBP6 MRPL45 MRPL1

1.39e-04941065int:MRPL35
InteractionCBX3 interactions

SET ESS2 MYO1E MCM2 CHD9 EFTUD2 BMI1 CHD5 DIAPH1 C1orf52 MGA HDAC2

1.50e-0464610612int:CBX3
InteractionCDC5L interactions

IPO5 ESS2 IPO7 DOCK8 XPA CCNB1 EFTUD2 SF3B1 VPS33B SF3B6 DIAPH1 PLEC MTREX DYNC1LI2

1.55e-0485510614int:CDC5L
InteractionARHGEF7 interactions

CBL EFTUD2 LATS1 PLEC VAV1 HDAC2

1.59e-041531066int:ARHGEF7
InteractionCDKN1A interactions

SET RBM48 TRRAP CCNB1 EFTUD2 BMI1 LATS2 CCNB2 HDAC2

1.63e-043751069int:CDKN1A
InteractionMCMBP interactions

IPO5 TPT1 APBA1 MCM2 EFTUD2 SKA3

1.82e-041571066int:MCMBP
InteractionYWHAH interactions

ZC3H14 MYO1E MCM2 PTPN21 CBL DNAH7 TTLL7 EFTUD2 UBA1 LATS1 LATS2 PLEC SKA3 MTREX PPIP5K2 CDC25C

2.03e-04110210616int:YWHAH
InteractionPRPSAP2 interactions

TPT1 CBL CCNB1 EFTUD2 VAV1

2.03e-041021065int:PRPSAP2
InteractionDDX39B interactions

ZC3H14 IPO7 MYO1E PHAX EFTUD2 BMI1 SF3B1 VPS33B PLEC IMMT DYNC1LI2

2.06e-0457010611int:DDX39B
InteractionTNPO1 interactions

IPO5 IPO8 IPO7 MYO1E RANBP6 IREB2 PHAX HDAC2

2.14e-043061068int:TNPO1
InteractionGRWD1 interactions

IPO7 CCNB1 EFTUD2 UBA1 SF3B1 ALDH1L2 MTREX MGA IMMT

2.18e-043901069int:GRWD1
InteractionSIAH2 interactions

MCM2 LATS1 LATS2 PIAS3 VAV1

2.23e-041041065int:SIAH2
InteractionOBSL1 interactions

ZC3H14 PCLO TUT7 MCM2 PTPN21 TRRAP EFTUD2 UBA1 SF3B1 PLEC MTREX MGA IMMT HDAC2

2.69e-0490210614int:OBSL1
InteractionREPIN1 interactions

SET IPO8 IPO7 BMI1 HDAC2

2.77e-041091065int:REPIN1
InteractionPHF5A interactions

MCM2 BMI1 LATS1 SF3B1 SF3B6 SKA3

2.89e-041711066int:PHF5A
InteractionPRKDC interactions

TPT1 MCM2 XPA RYK CCNB1 EFTUD2 BMI1 SF3B1 LATS2 SF3B6 DIAPH1 HDAC2

2.93e-0469510612int:PRKDC
InteractionSETSIP interactions

SET TRRAP SETSIP

2.99e-04251063int:SETSIP
InteractionDHX15 interactions

ATG5 IPO5 MCM2 TRRAP EFTUD2 SF3B1 SF3B6 MTREX UBE2Z HDAC2

3.16e-0450210610int:DHX15
InteractionQARS1 interactions

ESS2 MCM2 PTPN21 EFTUD2 UBA1 ADAMTS20 TGM7 PLEC HDAC2

3.27e-044121069int:QARS1
InteractionSIGLECL1 interactions

IPO8 IPO7 RANBP6 RNF213 RYK

3.28e-041131065int:SIGLECL1
InteractionHSPB1 interactions

ATG5 TPT1 IPO7 MCM2 RBM48 CBL TRRAP EFTUD2 LATS1 ACAP2 IMMT VAV1

3.46e-0470810612int:HSPB1
InteractionEP300 interactions

IPO5 SET IPO7 MCM2 XPA PHAX CBL CCNB1 BMI1 SF3B1 PIAS3 SETSIP SF3B6 MTREX SEC63 CDC25C IMMT HDAC2

3.54e-04140110618int:EP300
InteractionHSPA4L interactions

ATG5 IPO7 RNF213 RASGRP1 LATS2 DIAPH1 CDC25C

3.57e-042501067int:HSPA4L
InteractionCCNB2 interactions

MCM2 CCNB1 CCNB2 CDC25C

3.60e-04641064int:CCNB2
InteractionPTEN interactions

IPO5 SET IPO7 MCM2 CBL RYR3 EFTUD2 BMI1 UBA1 LATS1 SF3B1 PLEC ACAP2 EPHB1

3.62e-0492910614int:PTEN
InteractionATG16L1 interactions

ATG5 IPO5 ZC3H14 IPO8 IPO7 TUT7 RANBP6 UBA1 VPS33B SF3B6 SETD7 PLEC MTREX IMMT VAV1 HDAC2

3.64e-04116110616int:ATG16L1
InteractionUSP9X interactions

TPT1 UBE4B MCM2 PTPN21 PHAX EFTUD2 BPTF LATS1 LATS2

3.89e-044221069int:USP9X
InteractionEFNB1 interactions

IPO8 IPO7 RANBP6 RNF213 RYK TBC1D9 EPHB1

4.02e-042551067int:EFNB1
InteractionRBM6 interactions

TRRAP EFTUD2 BMI1 LATS1 PLEC

4.16e-041191065int:RBM6
InteractionWWC2 interactions

PTPN21 LATS1 LATS2

4.21e-04281063int:WWC2
InteractionRPGRIP1 interactions

IPO5 IPO8 IPO7 IQCE

4.30e-04671064int:RPGRIP1
InteractionSRSF3 interactions

IPO5 ZC3H14 ESS2 MCM2 MRPL45 PHAX EFTUD2 BMI1 SF3B1 MRPL1

4.30e-0452210610int:SRSF3
InteractionCALM1 interactions

TPT1 SET ESS2 MYO1E MCM2 CBL EFTUD2 BMI1 SF3B1 IMMT IQCE

4.58e-0462610611int:CALM1
InteractionTIMM50 interactions

IPO8 MCM2 TRRAP RYK EFTUD2 BMI1 VAV1

4.62e-042611067int:TIMM50
InteractionCSNK2A1 interactions

SET MCM2 PTPN21 TRRAP F5 TTLL7 EFTUD2 BMI1 SF3B1 SETSIP MTREX CDC25C MGA HDAC2

4.82e-0495610614int:CSNK2A1
InteractionCUL7 interactions

IPO5 ZC3H14 TUT7 EFTUD2 BPTF UBA1 SF3B1 LATS2 SF3B6 PLEC MTREX IMMT HDAC2

4.90e-0484510613int:CUL7
InteractionLIMD1 interactions

APBA1 PHAX UBR7 LATS1 LATS2

5.02e-041241065int:LIMD1
Cytoband6q21

ATG5 REV3L SEC63 HDAC2

7.57e-059610646q21
CytobandEnsembl 112 genes in cytogenetic band chr6q21

ATG5 REV3L SEC63 HDAC2

1.85e-041211064chr6q21
Cytoband4q28

SETD7 FGG

1.88e-04910624q28
Cytoband14q31.3

ZC3H14 PTPN21

4.05e-0413106214q31.3
Cytoband5q31

PCDHGA1 DIAPH1 CDC25C

2.45e-0311510635q31
GeneFamilyArmadillo repeat containing|Importins

IPO5 IPO8 IPO7

3.65e-0518663596
GeneFamilyEF-hand domain containing

CAPSL DNAH7 TBC1D9 RYR3 RASGRP1 ANKEF1

1.46e-04219666863
GeneFamilyPHD finger proteins|NuRD complex

CHD5 HDAC2

8.46e-04126621305
GeneFamilyDyneins, axonemal

DNAH10 DNAH7

1.72e-0317662536
CoexpressionZERBINI_RESPONSE_TO_SULINDAC_DN

CCNB1 CCNB2 CDC25C

1.24e-0661053M17956
CoexpressionGABRIELY_MIR21_TARGETS

IREB2 NBEA REV3L RASGRP1 LATS1 SEC63 MGA ACAP2 DYNC1LI2

2.53e-062891059M2196
CoexpressionGSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP

IPO7 POMGNT1 MCM2 PLA2G15 BMI1 UBA1 MGA

1.64e-052001057M3774
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G6

CHD9 XPA REV3L CCNB1 FAT2 CCNB2

2.65e-051451056M1810
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

CHD9 XPA REV3L CCNB1 BPTF FAT2 CCNB2 PPIP5K2

2.86e-053001058M8702
CoexpressionWHITFIELD_CELL_CYCLE_LITERATURE

MCM2 CCNB1 CCNB2 CDC25C

2.92e-05441054M2066
CoexpressionCUI_TCF21_TARGETS_2_DN

MYO1E TUT7 ASH1L CBL TTLL7 BMI1 LATS2 SCN7A SETD7 PPIP5K2 ACAP2 DYNC1LI2 EPHB1

3.75e-0585410513M1533
CoexpressionSIMBULAN_PARP1_TARGETS_DN

SET CCNB1 CCNB2

4.08e-05171053M1642
CoexpressionCUI_TCF21_TARGETS_2_DN

MYO1E TUT7 ASH1L CBL TTLL7 BMI1 LATS2 SCN7A SETD7 PPIP5K2 ACAP2 DYNC1LI2 EPHB1

5.58e-0588810513MM1018
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

IPO5 TUT7 REV3L PHAX TBC1D9 TTLL7 BPTF MTREX PPIP5K2 SEC63 HDAC2

6.57e-0565610511M18979
CoexpressionGSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN

IPO5 ZC3H14 MYO1E IREB2 SEC63 HDAC2

8.58e-051791056M8928
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

IPO5 MCM2 NBEA REV3L UBR7 CCNB1 CCNB2 ALDH1L2 SKA3 PPIP5K2 CDC25C

9.04e-0568010511MM456
CoexpressionGSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP

IPO8 POMGNT1 NBEA REV3L CCNB2 IMMT

1.09e-041871056M6807
CoexpressionGSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN

IPO5 IPO7 MCM2 CCNB1 CCNB2 CDC25C

1.53e-041991056M8314
CoexpressionGSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN

IPO5 IPO7 CCNB1 CCNB2 CDC25C IMMT

1.53e-041991056M8299
CoexpressionGSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN

SET REV3L UBR7 PIAS3 CCNB2 MGA

1.57e-042001056M7709
CoexpressionGSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP

ZC3H14 CHD9 XPA REV3L SF3B1 PPIP5K2

1.57e-042001056M3277
CoexpressionGSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN

IPO5 MCM2 CCNB1 CCNB2 CDC25C IMMT

1.57e-042001056M5292
CoexpressionGSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN

IPO8 ASH1L RYK BMI1 RASGRP1 ACBD4

1.57e-042001056M7868
CoexpressionGSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN

RASGRP1 SF3B1 C1orf52 IRF2BPL PLEC LRRC23

1.57e-042001056M9763
CoexpressionGSE557_CIITA_KO_VS_I_AB_KO_DC_DN

IPO5 ZC3H14 ENPP1 POMGNT1 IMMT HDAC2

1.57e-042001056M6014
CoexpressionGSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP

ATG5 UBR7 SF3B1 LATS2 CTSE HDAC2

1.57e-042001056M6950
CoexpressionCROONQUIST_NRAS_SIGNALING_DN

MCM2 CCNB1 CCNB2 CDC25C

1.82e-04701054M10739
CoexpressionMUELLER_PLURINET

SET MCM2 CCNB1 CCNB2 DIAPH1 CDC25C HDAC2

2.05e-042991057M123
ToppCell390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells)

MCM2 MYRFL CCNB1 CCNB2 CDC25C NYAP1

2.26e-0615910660fbfdb18b7ed4bde077add13f2b3636e144b254f
ToppCellTCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9

MYO1E DOCK8 CAPSL TBC1D9 FAT2 PIAS3

2.61e-061631066d64dd39b077105c73e570ccef70f0e74a2c586ac
ToppCellHealthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class

MCM2 PKHD1L1 CCNB2 ALDH1L2 ANKEF1 CDC25C

3.80e-06174106697d19ef3240a1f648c6befaabb9ce45ad469cbce
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

NYAP2 MYO1E MCM2 PKHD1L1 TTLL7 CCNB2

3.93e-06175106689bf89466191da14896ed8928027f5b911436c22
ToppCellmild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2)

RGPD1 MCM2 CCNB1 CCNB2 SKA3 CDC25C

4.92e-0618210669adf90bb2808f234d53b89ca0ae07380478204ad
ToppCellmild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

RGPD1 MCM2 CCNB1 CCNB2 SKA3 CDC25C

5.08e-061831066df8568751205313d149939ea2683097e3652a60b
ToppCellP07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MCM2 CCNB1 CCNB2 SCN7A SKA3 CDC25C

6.89e-0619310661e95ef29357969ee385b4717c0b5a497390ac260
ToppCellP07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MCM2 CCNB1 CCNB2 SCN7A SKA3 CDC25C

6.89e-0619310660f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MCM2 PKHD1L1 CCNB1 CCNB2 SKA3 CDC25C

7.09e-0619410665771a28a61f4d9b5479891f3224909ab003cb241
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MCM2 PKHD1L1 CCNB1 CCNB2 SKA3 CDC25C

7.09e-0619410665a519538327029ad2b880ef9647e2ac6ab3961a4
ToppCelldroplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MCM2 TBC1D9 CCNB1 CCNB2 SKA3 CDC25C

7.30e-061951066c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCLO ASH1L NBEA REV3L TTLL7 MGA

7.30e-0619510663e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCLO ASH1L NBEA REV3L TTLL7 MGA

7.30e-0619510667796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MCM2 CCNB1 SETSIP DSEL DYNC1LI2 EPHB1

7.52e-0619610668faac7fbdee3a9297023c3151ef1751605413e44
ToppCellMS-cycling-|MS / Condition, Cell_class and T cell subcluster

MCM2 PKHD1L1 CCNB1 CCNB2 SKA3 CDC25C

7.97e-06198106619c5d6b65de490118574b1f86b45c58b3a51df7f
ToppCellLPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type

DNAH10 CAPSL MRPL45 DNAH7 IQCE KLB

7.97e-0619810666d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCellMS-cycling|MS / Condition, Cell_class and T cell subcluster

MCM2 PKHD1L1 CCNB1 CCNB2 SKA3 CDC25C

7.97e-0619810660c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MCM2 CCNB1 CCNB2 SKA3 CDC25C HDAC2

7.97e-061981066cd876fba12ff30b74aa507286cb1f3a867011a92
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MCM2 CCNB1 CCNB2 SKA3 CDC25C CTSE

8.20e-061991066d7dbc551c05da32c698908348572fb0ce1166e10
ToppCellproximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MCM2 CCNB1 FAT2 CCNB2 SKA3 CDC25C

8.20e-061991066521ff4ae3437c8ba477a0a42b9da195af976c3ff
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MCM2 CCNB1 CCNB2 SKA3 CDC25C CTSE

8.20e-061991066f0944961f99c600ad5fa588b19321fce991258f7
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MCM2 CCNB1 CCNB2 SKA3 CDC25C CTSE

8.20e-0619910666a89c3a65fa50af92585c52bec203bcff6f94efc
ToppCellproximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MCM2 CCNB1 FAT2 CCNB2 SKA3 CDC25C

8.20e-061991066e8549b2c4152cb23548351d9cee27c3805892cd8
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MCM2 CCNB1 CCNB2 SKA3 CDC25C CTSE

8.20e-06199106699437f8b57d168c550ccfd1fbda5454c26f971a8
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

TPT1 NYAP2 PCLO NBEA BPTF CHD5

8.20e-0619910661b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCellproximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MCM2 CCNB1 FAT2 CCNB2 SKA3 CDC25C

8.20e-0619910662263bb73d9c5693b44d91d2548305efc1b6e4079
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

TPT1 NYAP2 PCLO NBEA BPTF CHD5

8.20e-0619910664bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCellSepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class

ZC3H14 MYO1E PKHD1L1 CCNB1 CCNB2 SKA3

8.20e-0619910660df6cafb7f3b607cbe80b6f25b4fd62d421d01ee
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 CAPSL DNAH7 ANKEF1 LRRC23

3.48e-0515510655f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 CAPSL DNAH7 ANKEF1 LRRC23

3.48e-0515510650944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PKHD1L1 TBC1D9 TTLL7 ALDH1L2 TBCEL

4.56e-051641065cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PKHD1L1 TBC1D9 TTLL7 ALDH1L2 TBCEL

4.56e-051641065e00549bc8b3a5566f39031f39d7e698b0b107a7f
ToppCell3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCNB1 CCNB2 SKA3 CDC25C HDAC2

4.69e-0516510650ae39c9a6d1265d65dc0660924612cfe11e489ec
ToppCell3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCNB1 CCNB2 SKA3 CDC25C HDAC2

4.69e-051651065686cf89077cc7b744a6127de2b34d8c27da8b6c4
ToppCell3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCNB1 CCNB2 SKA3 CDC25C HDAC2

4.69e-051651065a5ed8c331d5551cd8bce50bdc31cb893218317cd
ToppCelldroplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

F5 WDR93 NYAP1 CTSE ECE2

4.83e-051661065de319c960b0cd90b294f677d1ea1b013a2ce2d53
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYO1E F5 RYR3 SCN7A ENPEP

5.11e-051681065fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYO1E F5 RYR3 SCN7A ENPEP

5.11e-051681065e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPT1 DNAH10 PCLO PKHD1L1 RYR3

5.26e-05169106512bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells)

MCM2 CCNB1 CCNB2 SKA3 CDC25C

5.41e-0517010655319f73cff64f2bb67472c7156ee1d0f006c6fc0
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

CCNB1 RASGRP1 CCNB2 SKA3 CDC25C

5.56e-0517110654ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCellHealthy/Control-Plasmablast|World / Disease group and Cell class

MCM2 PKHD1L1 CCNB2 ALDH1L2 ANKEF1

5.71e-051721065d3bfcf5d936152b71cd90f955f9331709edd979e
ToppCellPND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CCNB1 CCNB2 CHD5 SKA3 CDC25C

5.71e-0517210651171e754fd503a0c1152162fcc12a115088a08c7
ToppCellURO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type

MYO1E PKHD1L1 CCNB1 CCNB2 SKA3

5.71e-05172106548888ef50ac784b38aca81da68f8a94ce09c670d
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPT1 DNAH10 PCLO PKHD1L1 RYR3

5.87e-05173106566f37c1437705734b20601656fa4aa1d92ca30be
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPT1 DNAH10 PCLO PKHD1L1 RYR3

5.87e-051731065649b08a409095592cccf31883be69c754411280d
ToppCellPND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPT1 ZC3H14 MCM2 TBC1D9 DSEL

6.04e-05174106509b091e24317c3f7bac043f04762a533e30793de
ToppCellControl-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations)

ATG5 ERN1 TBC1D9 ALDH1L2 TBCEL

6.20e-051751065fb23858cfce71509cafbe0d9728e678012ff2962
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MCM2 CCNB1 CCNB2 SKA3 CDC25C

6.20e-0517510650b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

MCM2 CCNB1 CCNB2 SKA3 CDC25C

6.20e-0517510656b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32

CCNB1 SF3B1 CCNB2 SKA3 CDC25C

6.37e-051761065d70fdc7bc48719776ed1e7c01118385e3a21623f
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32

CCNB1 SF3B1 CCNB2 SKA3 CDC25C

6.37e-051761065a84361308e5e96f3a30246cd29e109c321ee65bf
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells)

UBR7 CCNB1 CCNB2 SKA3 CDC25C

6.37e-0517610654bba41ebf9dd187c8705a6997ed039878de62b4e
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells)

MCM2 CCNB1 CCNB2 SKA3 CDC25C

6.55e-051771065ba701d3c90722d8bff70d0fa651899305cdad257
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 CAPSL WDR93 ANKEF1 SCN7A

6.72e-051781065b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 CAPSL WDR93 ANKEF1 SCN7A

6.72e-051781065579cdc14f28b459e200ae2102e0bd4df8a2c0dcb
ToppCelldroplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CCNB1 CCNB2 SKA3 CDC25C MRPL1

6.90e-051791065af03705a783e77f75c44fdfa793cfdccbf9dd91c
ToppCellTCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9

PCLO NBEA TBC1D9 TTLL7 IGSF1

6.90e-051791065431e1b29015ec817f778499106d24b19cfc825ae
ToppCellControl-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

MCM2 CCNB1 CCNB2 SKA3 CDC25C

6.90e-0517910659383568f78b07b8cca72ece5d15fea209aa54ea9
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH10 DNAH7 TTLL7 WDR93 LRRC23

7.09e-05180106592fb01b91261b3103454924cde56add337b41844
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CCNB1 CCNB2 SCN7A SKA3 CDC25C

7.09e-051801065b35a8c6169f4b548b912af005e92ae7c6596f376
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells)

RNF213 F5 RASGRP1 PIAS3 MRPL1

7.27e-051811065b193f3606554adc55c5906219d114288bb1f978a
ToppCellP28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MCM2 CCNB1 CCNB2 SKA3 CDC25C

7.27e-051811065e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d
ToppCellP28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MCM2 CCNB1 CCNB2 SKA3 CDC25C

7.27e-0518110652be3d44619adb25d339e7a27b500a56e07e8de01
ToppCellfacs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCNB1 CCNB2 SKA3 CDC25C CTSE

7.47e-051821065bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCelldroplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK8 CAPSL CHD9 DIAPH1 ENPEP

7.47e-051821065f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCNB1 CCNB2 SKA3 ENPEP LRRC23

7.47e-051821065c84f44391932080df31c8765e363c3dff64b2bd1
ToppCellfacs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCNB1 CCNB2 SKA3 CDC25C CTSE

7.47e-0518210650fc45214f0b0766f69be6eff69cc4bec574023aa
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

MCM2 CCNB1 CCNB2 SKA3 CDC25C

7.66e-051831065a48a6313f2f144586951cece97ec31f6d72361df
ToppCell18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class

CAPSL MYRFL CCNB1 SKA3 LRRC23

7.66e-051831065a75cda2131755931117c387f2e0ae3394efa8e80
ToppCelldroplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TBC1D9 CCNB1 CCNB2 SKA3 CDC25C

7.66e-051831065e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32

SET MCM2 CCNB1 CCNB2 SKA3

7.66e-051831065f20b0d71f857ac35868fd80531050ad8b6091716
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PCLO PKHD1L1 RYR3 ADAMTS20

7.86e-0518410652cbed6462fea2622871bb7e49b0df3d984239281
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

REV3L ALDH1L2 SCN7A SETD7 SEC63

7.86e-05184106567164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PCLO PKHD1L1 RYR3 ADAMTS20

7.86e-051841065ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellControl-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients

DNAH10 RYK SF3B6 IRF2BPL MGA

7.86e-051841065ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 PCLO PKHD1L1 RYR3 ADAMTS20

7.86e-0518410652b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellCOVID-cycling-|COVID / Condition, Cell_class and T cell subcluster

CCNB1 CCNB2 SKA3 CDC25C CTSE

8.06e-051851065eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f
ToppCellCOVID-cycling|COVID / Condition, Cell_class and T cell subcluster

CCNB1 CCNB2 SKA3 CDC25C CTSE

8.06e-0518510655112f966735fa48f0606adcfd5c0212ad5d3d77a
ToppCellmild_COVID-19-Plasmablast|mild_COVID-19 / disease group, cell group and cell class (v2)

PKHD1L1 CCNB1 CCNB2 ALDH1L2 SKA3

8.27e-051861065a639d2183b85b1be6e6da2b2e112aec5149d5bcd
ToppCell10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue

CCNB1 CCNB2 SKA3 CDC25C CTSE

8.48e-05187106561d346c9873c2edb3ce224a0c063c54d9a68309e
ToppCellsevere_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2)

PKHD1L1 CCNB1 CCNB2 ALDH1L2 SKA3

8.70e-05188106525ca19af4ac419a0f5026a6ccbd8b554b268a6f3
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type

MCM2 CCNB1 CCNB2 SKA3 CDC25C

8.70e-0518810656c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCellnormal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex

MCM2 CCNB1 CCNB2 SKA3 CDC25C

8.92e-0518910651d382f8eb998c6a30e09fddc9a427afc8f5f7323
ToppCellnormal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex

MCM2 CCNB1 CCNB2 SKA3 CDC25C

8.92e-051891065b83fd81ecc5ef363be7435ee12cb7079e2434af7
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH10 CAPSL DNAH7 IQCE LRRC23

8.92e-051891065b4b93bd10b7e3cc16e54ff73beac230f519c010a
ToppCellnormal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

MCM2 CCNB1 CCNB2 SKA3 CDC25C

8.92e-0518910653db4177d68cab4cd16842d2ebcaca28f69300e44
ToppCellInt-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type

MCM2 CCNB1 CCNB2 SKA3 CDC25C

9.14e-051901065005967c540418b85311308072a07c684f4296aef
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCNB1 CCNB2 ADAMTS20 SKA3 NYAP1

9.14e-051901065b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MCM2 CCNB1 CCNB2 SKA3 CDC25C

9.37e-05191106515dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCellfacs-Trachea-nan-3m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCM2 CCNB1 RASGRP1 CDC25C CTSE

9.37e-05191106589eb4e30052d0d4a2952157ca743291900ce8de2
ToppCellfacs-Trachea-nan-3m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCM2 CCNB1 RASGRP1 CDC25C CTSE

9.37e-0519110650bf575eba311745fb75f9523f7fc81f73848e25d
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MCM2 CCNB1 CCNB2 SKA3 CDC25C

9.37e-05191106545c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCellfacs-Trachea-nan-3m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MCM2 CCNB1 RASGRP1 CDC25C CTSE

9.37e-051911065c57df363e3a6e61d2bdca1955330f1899b964267
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

MCM2 CCNB1 CCNB2 SKA3 CDC25C

9.37e-05191106556b45259dfc38bd5ea43b0e3adf47e7e2c043a5d
ToppCelldroplet-Tongue-Unstain-18m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPT1 MCM2 CCNB1 CCNB2 CDC25C

9.60e-05192106545ff9555f9a9fccc650885956005b2e5b4820a56
ToppCelldroplet-Tongue-Unstain|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPT1 MCM2 CCNB1 CCNB2 CDC25C

9.60e-0519210650f0fae7e1177609eff82fa4452042306297a7103
ToppCelldroplet-Tongue-Unstain-18m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPT1 MCM2 CCNB1 CCNB2 CDC25C

9.60e-051921065b198e42a962c4e24ea9faad867ca1255316a5d99
ToppCellnormal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass

MCM2 CCNB1 CCNB2 SKA3 CDC25C

9.84e-0519310655ce93860bc60ce6ecfed3a3d985f84e28781eec1
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

MCM2 CCNB1 CCNB2 SKA3 CDC25C

9.84e-051931065cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ComputationalGenes in the cancer module 57.

MCM2 CCNB1 CCNB2 CDC25C HDAC2

4.75e-0556775MODULE_57
ComputationalNeighborhood of PRKDC

MCM2 TRRAP BMI1 DIAPH1 MTREX SEC63 IMMT HDAC2

6.33e-05191778MORF_PRKDC
ComputationalNeighborhood of RFC4

SET MCM2 TRRAP MTREX SEC63 IMMT HDAC2

9.92e-05151777MORF_RFC4
ComputationalNeighborhood of RAD54L

MCM2 TRRAP MTREX SEC63 IMMT HDAC2

1.02e-04105776MORF_RAD54L
ComputationalNeighborhood of BUB1B

IPO5 MCM2 MTREX IMMT HDAC2

1.05e-0466775MORF_BUB1B
ComputationalNeighborhood of PPP1CC

IPO5 IPO7 MCM2 MTREX SEC63 IMMT HDAC2

1.79e-04166777MORF_PPP1CC
ComputationalNeighborhood of MLL

IPO5 THUMPD1 CHD9 UBR7 BPTF NAA25 C1orf52

2.39e-04174777GCM_MLL
ComputationalNeighborhood of BUB1

CCNB1 MTREX IMMT HDAC2

5.08e-0452774MORF_BUB1
ComputationalNeighborhood of MSH2

SET MCM2 TRRAP HDAC2

9.32e-0461774MORF_MSH2
ComputationalNeighborhood of PAK2

TUT7 ACAP2 VAV1

1.02e-0328773GNF2_PAK2
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

ATG5 CHD9 REV3L TRRAP TBC1D9 BPTF RASGRP1 MGA ACAP2

1.93e-0718310697498_DN
Drug1m0o

CCNB1 LATS1 SF3B1 CCNB2 CDC25C

6.29e-06561065CID006323413
DiseaseIntellectual Disability

ZC3H14 SET DOCK8 ASH1L NBEA XPA TRRAP UBR7 BPTF DIAPH1

4.23e-0644710410C3714756
Diseasehepatocellular carcinoma (is_implicated_in)

ERN1 RYR3 AZIN1 EFTUD2 BMI1 SF3B1

4.52e-051811046DOID:684 (is_implicated_in)
Diseasephospholipids in large VLDL measurement

NYAP2 DNAH10 TM6SF2 BPTF

6.94e-05621044EFO_0022169
Diseasebenign neoplasm (implicated_via_orthology)

LATS1 LATS2

3.40e-0481042DOID:0060072 (implicated_via_orthology)
DiseaseGastric Adenocarcinoma

ERN1 TRRAP EPHB1

5.42e-04451043C0278701
Diseasekidney cancer (implicated_via_orthology)

LATS1 LATS2

6.63e-04111042DOID:263 (implicated_via_orthology)
DiseaseAdenocarcinoma of lung (disorder)

IPO5 ERN1 LATS1 LATS2 VAV1

8.30e-042061045C0152013
Diseaseplatelet measurement

DOCK8 CHD9 CBL PLEC NYAP1 VAV1

8.92e-043151046EFO_0005036
Diseasetriglycerides in medium VLDL measurement

NYAP2 DNAH10 TM6SF2

9.77e-04551043EFO_0022155
DiseaseSquamous cell carcinoma

DOCK8 XPA UBA1 HDAC2

9.88e-041241044C0007137
Diseasetriglycerides in large VLDL measurement

NYAP2 DNAH10 TM6SF2

1.03e-03561043EFO_0022178
DiseaseAutosomal recessive limb-girdle muscular dystrophy

POMGNT1 PLEC

1.09e-03141042cv:C2931907
Diseasetriglycerides in small VLDL measurement

NYAP2 DNAH10 BPTF

1.32e-03611043EFO_0022145
Diseasevery low density lipoprotein cholesterol measurement, phospholipid measurement

NYAP2 DNAH10 TM6SF2 BPTF TGM7

1.33e-032291045EFO_0004639, EFO_0008317
Diseasetotal lipids in very large VLDL measurement

NYAP2 DNAH10 TM6SF2

1.38e-03621043EFO_0022313
Diseasephospholipids in very large VLDL measurement

NYAP2 DNAH10 TM6SF2

1.38e-03621043EFO_0022299
Diseaseendometriosis (biomarker_via_orthology)

VAV1 HDAC2

1.43e-03161042DOID:289 (biomarker_via_orthology)
Diseaselevel of Phosphatidylethanolamine (16:0_20:4) in blood serum

NYAP2 MYO1E

1.43e-03161042OBA_2045137
Diseasecholesterol in large VLDL measurement

NYAP2 DNAH10 TM6SF2

1.59e-03651043EFO_0021902
Diseasecholesterol in very large VLDL measurement

NYAP2 DNAH10 TM6SF2

1.59e-03651043EFO_0022230
Diseaserhinitis

CAPSL RANBP6

1.62e-03171042EFO_0008521
DiseaseIschemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism

F5 FGG

1.62e-03171042EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
DiseaseLiver Cirrhosis, Experimental

ERN1 NBEA TBC1D9 ACBD4 CCNB2 ALDH1L2 CTSE ENPEP VAV1

1.68e-037741049C0023893
Diseasetotal lipids in large VLDL

NYAP2 DNAH10 TM6SF2

1.73e-03671043EFO_0022175
DiseaseMYELODYSPLASTIC SYNDROME

CBL BMI1 SF3B1

1.73e-03671043C3463824
Diseasefree cholesterol in large VLDL measurement

NYAP2 DNAH10 TM6SF2

1.81e-03681043EFO_0022265
Diseasevisceral:subcutaneous adipose tissue ratio

NYAP2 DNAH10 EPHB1

1.96e-03701043EFO_0004767
Diseasebody mass index, high density lipoprotein cholesterol measurement

NYAP2 DNAH10

2.02e-03191042EFO_0004340, EFO_0004612
Diseasetype 1 diabetes mellitus (biomarker_via_orthology)

CBL VAV1

2.02e-03191042DOID:9744 (biomarker_via_orthology)
Diseasetriglyceride measurement, body mass index

NYAP2 DNAH10

2.02e-03191042EFO_0004340, EFO_0004530
Diseasetriglyceride measurement, body fat percentage

NYAP2 DNAH10

2.47e-03211042EFO_0004530, EFO_0007800
Diseaseprothrombin time measurement

F5 FGG

2.47e-03211042EFO_0008390
Diseasevenous thromboembolism, plasminogen activator inhibitor 1 measurement

F5 FGG

2.47e-03211042EFO_0004286, EFO_0004792
Diseasedisease

RASGRP1 ACBD4

2.47e-03211042EFO_0000408
Diseasecancer (implicated_via_orthology)

IPO5 RANBP6 LATS1 LATS2 ACAP2

2.64e-032681045DOID:162 (implicated_via_orthology)
DiseaseOvarian Serous Adenocarcinoma

ERN1 TRRAP

2.97e-03231042C1335177
Diseasevenous thromboembolism, tissue plasminogen activator measurement

F5 FGG

2.97e-03231042EFO_0004286, EFO_0004791
Diseasecholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

NYAP2 DNAH10 TM6SF2 AZIN1 BPTF

2.99e-032761045EFO_0004612, EFO_0020943
Diseasepartial thromboplastin time

F5 FGG

3.23e-03241042EFO_0004310
Diseasemean platelet volume

SET MYO1E DOCK8 PCDHGA1 CHD9 AZIN1 DIAPH1 PLEC ACAP2 VAV1

3.24e-03102010410EFO_0004584
Diseaseresponse to anticonvulsant

C1orf52 ADAMTS20 IRF2BPL

3.41e-03851043GO_0036277
DiseaseCerebral Astrocytoma

LATS1 LATS2

3.50e-03251042C0750935
DiseaseIntracranial Astrocytoma

LATS1 LATS2

3.50e-03251042C0750936
DiseaseAstrocytoma

LATS1 LATS2

3.50e-03251042C0004114
DiseaseGrade I Astrocytoma

LATS1 LATS2

3.50e-03251042C1704230
DiseaseSubependymal Giant Cell Astrocytoma

LATS1 LATS2

3.50e-03251042C0205768
DiseaseMixed oligoastrocytoma

LATS1 LATS2

3.50e-03251042C0547065
DiseasePilocytic Astrocytoma

LATS1 LATS2

3.50e-03251042C0334583
DiseaseJuvenile Pilocytic Astrocytoma

LATS1 LATS2

3.50e-03251042C0280783
DiseaseDiffuse Astrocytoma

LATS1 LATS2

3.50e-03251042C0280785
DiseaseChildhood Cerebral Astrocytoma

LATS1 LATS2

3.50e-03251042C0338070
Diseasebody fat percentage, high density lipoprotein cholesterol measurement

NYAP2 DNAH10

3.50e-03251042EFO_0004612, EFO_0007800

Protein segments in the cluster

PeptideGeneStartEntry
ALKDMPAGTELTYDY

ASH1L

2246

Q9NR48
KMLDLLEDFLEYEGY

CHD5

1051

Q8TDI0
GEVAEDMFGYFEPLY

ACBD4

106

Q8NC06
GVEKTGSDEPAFMYY

AZIN1

301

O14977
EDYMYLAKEESFGPI

ALDH1L2

816

Q3SY69
YEAMPDYLEDGKVNV

RASGRP1

366

O95267
AFESGIPVDMKDNYY

ANKEF1

511

Q9NU02
GYDLFSELGPYMKDL

ACAP2

206

Q15057
MAAEEKDPLSYFAAY

C1orf52

1

Q8N6N3
KLMEYPAEENGFRYI

ATG5

171

Q9H1Y0
METLYKELGEYFLFD

DIAPH1

1111

O60610
APDYYGVIKEPMDLA

BPTF

2961

Q12830
EYFLEPIMKADGNEY

ADAMTS20

161

P59510
YPAEDFTEVYLIKFM

RBM48

81

Q5RL73
GPYFLALREMIEEMY

PLA2G15

171

Q8NCC3
MDAPKAGYAFEYLIE

IREB2

1

P48200
GTPVYREKEDMYDEI

IQCE

136

Q6IPM2
EAALEVVLAMYPKYD

MCM2

261

P49736
MKIYIDPFTYEDPNE

EPHB1

591

P54762
REEDKDPVYLYFESM

MGA

1221

Q8IWI9
DNLYFVMDYIPGGDM

LATS1

776

O95835
QDKDSLYFVMDYIPG

LATS2

736

Q9NRM7
IDVMYEEEPLKDYYT

BMI1

191

P35226
EEEPLKDYYTLMDIA

BMI1

196

P35226
AKEPLINYLDMEYFG

CTSE

66

P14091
KFVKDFQDYMEPEEG

DYNC1LI2

176

O43237
EKADAIYDMIGFPDF

ECE2

536

P0DPD6
MKDHYIFYCEGRDPE

LCN1P1

111

Q5VSP4
MPYLERLDKEFYEEE

LRRC23

296

Q53EV4
PGMDYELKLFIEYPT

IRF2BPL

411

Q9H1B7
FEKEPLYGGMLIEDY

PCLO

1941

Q9Y6V0
YVESFEKMGIYLAEP

FAT2

51

Q9NYQ8
DPYEYIRMKFDVFED

IPO7

371

O95373
MKPDRDTLDEYFEYD

FAM214A

1

Q32MH5
IVEYDYKPEFASAMG

MYRFL

476

Q96LU7
YSDKLFEMVLGPAAY

IMMT

81

Q16891
DVEINGIFPDIYKMY

ENPP1

326

P22413
FEDDKELYPMIEEYF

ENPEP

706

Q07075
AVYEEMKYPIFDDLG

NYAP2

266

Q9P242
DTAEEKFVPYYDLFM

IPO5

521

O00410
ILKGGYRDFFPEYME

CDC25C

411

P30307
VERMDGYGEESYPAK

PTPN21

211

Q16825
ADYAMFKVGPEADKY

FGG

286

P02679
KNSLMYYPEGVPDEE

ESS2

221

Q96DF8
DYMDGDVEDPEYKPA

CHD9

1726

Q3L8U1
SKYEEMYPPEIGDFA

CCNB1

256

P14635
FMLFKEGYAEPVDYQ

IGSF1

161

Q8N6C5
TFVEPYFDEYEMKDR

DOCK8

1866

Q8NF50
DKDGLVTPEEFMNYY

CAPSL

171

Q8WWF8
KYEEMFSPNIEDFVY

CCNB2

221

O95067
DYAASLPEDDVDYKM

ERN1

181

O75460
DLLGFDYEVMEDKEY

DNAH7

3901

Q8WXX0
KEAEFAPYPRMDSYE

APBA1

251

Q02410
LFKTGDYPAAMREYI

KLB

776

Q86Z14
PGYMAFLTYDEVKAR

CBL

266

P22681
KYYAVNFPMRDGIDD

HDAC2

221

Q92769
FEKYVPYLMDVIVEG

DNAH10

2281

Q8IVF4
IDPFEMAAYLKDGYR

RYK

546

P34925
PEDKVAFEFVLEYMD

DSEL

136

Q8IZU8
PEMNYKGRYEITAED

PHAX

211

Q9H814
MQELEDYSEGGPLYK

RGPD1

741

P0DJD0
ISNKEPLDFEEYKMY

PCDHGA1

301

Q9Y5H4
EDPYEYIRMKFDIFE

IPO8

371

O15397
YEEMKYPLPEEAGEG

NYAP1

261

Q6ZVC0
EKMDDAVAPGREYTY

F5

136

P12259
LMYGQEDVPKDVLEY

MRPL45

231

Q9BRJ2
FIDGYYEEPMDVVAL

POMGNT1

336

Q8WZA1
VKELIPEFYYLPEMF

NBEA

2431

Q8NFP9
QYYLVPDMDDEEGGE

SETSIP

241

P0DME0
DGEMTGEKIAYVYPD

SETD7

136

Q8WTS6
QYYLVPDMDDEEGEG

SET

231

Q01105
IEEKFVPYYDIFMPS

RANBP6

531

O60518
FLYYEDMKENPKEEI

SULT1B1

191

O43704
DVTMKPLPFYEVYGE

PIAS3

126

Q9Y6X2
GEESDFEDYPMRILY

SKA3

31

Q8IX90
PGQMDRYLVYGDEYK

RNF213

4321

Q63HN8
PYMEGEPEDDVYLKR

MRPL1

76

Q9BYD6
VEEINPEYMLEKSFY

MTREX

576

P42285
VGYMYETLDQKDPVF

REV3L

2836

O60673
DPAGDPYEMYRIVFD

RYR3

4736

Q15413
MGKDYIYAVTPLLED

SF3B1

1161

O75533
LPYKITAEEMYDIFG

SF3B6

26

Q9Y3B4
TAEEMYDIFGKYGPI

SF3B6

31

Q9Y3B4
LDSDYFKYPLMALGE

UBE4B

536

O95155
ELGLPKMEVFQEYYG

VAV1

591

P15498
YREDGVTPYMIFFKD

TPT1

151

P13693
LFGMPEEEKLVNYYS

TBC1D9

151

Q6ZT07
KYEEVMAVLGSFPYV

SEC63

431

Q9UGP8
EEILEYNEKTPGYMG

PKHD1L1

356

Q86WI1
VDPETGKEMSVYEAY

PLEC

4281

Q15149
PLRGVMEKSFLEYYD

UBE2Z

266

Q9H832
GFKMYPIDFEKDDDS

UBA1

841

P22314
YGPEENLEDDMYRKT

XPA

246

P23025
PVDEMGIIRLFYFYK

WDR93

161

Q6P2C0
KMYGDLDVLFLTDEY

UBR7

321

Q8N806
MVSEPLEDVDPYYYK

SCN7A

61

Q01118
GFMEFYTKEGEPYLR

TM6SF2

91

Q9BZW4
YEEFMPTDGTDVKVY

PPIP5K2

236

O43314
MDTDLYDEFGNYIGP

EFTUD2

1

Q15029
YKYPEGSPEERAVFM

TGM7

446

Q96PF1
DYPSKMEYFFDPDVL

TUT7

1321

Q5VYS8
ELGAYVDEELPDYIM

ZC3H14

21

Q6PJT7
FLKEYMEEEIPKNYS

TRRAP

1731

Q9Y4A5
YYFDHEAPFGPEEMK

TBCEL

386

Q5QJ74
NEYGDDMYGPEKFTD

THUMPD1

66

Q9NXG2
YDLKVPRDMAYVFGG

VPS33B

501

Q9H267
IVQEYIEKPFLMEGY

TTLL7

186

Q6ZT98
PYFGEKEIEMYQGAA

MYO1E

66

Q12965
DEYKLGDPEELMFQY

NAA25

341

Q14CX7